ACADIAN ASSET MANAGEMENT LLC - CHAMPIONS ONCOLOGY INC ownership

CHAMPIONS ONCOLOGY INC's ticker is CSBR and the CUSIP is 15870P307. A total of 17 filers reported holding CHAMPIONS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of CHAMPIONS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$190
-0.5%
30,6970.0%0.00%0.0%
Q2 2023$191
+54.0%
30,697
-2.5%
0.00%0.0%
Q1 2023$124
-11.4%
31,4760.0%0.00%0.0%
Q4 2022$140
-99.9%
31,4760.0%0.00%0.0%
Q3 2022$234,000
-7.1%
31,4760.0%0.00%0.0%
Q2 2022$252,000
-1.2%
31,4760.0%0.00%0.0%
Q1 2022$255,000
-2.3%
31,4760.0%0.00%0.0%
Q4 2021$261,000
-18.4%
31,4760.0%0.00%0.0%
Q3 2021$320,000
-1.2%
31,476
-0.0%
0.00%0.0%
Q2 2021$324,000
-9.0%
31,4770.0%0.00%0.0%
Q1 2021$356,000
+20.7%
31,477
+14.8%
0.00%0.0%
Q4 2020$295,000
+26.6%
27,427
+8.5%
0.00%0.0%
Q3 2020$233,000
+18.9%
25,284
+23.4%
0.00%0.0%
Q2 2020$196,000
+45.2%
20,482
+11.9%
0.00%0.0%
Q1 2020$135,000
-11.2%
18,2980.0%0.00%0.0%
Q4 2019$152,000
-48.1%
18,298
-64.7%
0.00%0.0%
Q3 2019$293,000
-69.0%
51,878
-56.9%
0.00%
-80.0%
Q2 2019$944,000
-19.1%
120,485
+1.1%
0.01%0.0%
Q1 2019$1,167,000
+39.6%
119,220
+11.2%
0.01%
+25.0%
Q4 2018$836,000
-33.1%
107,173
+49.9%
0.00%
-20.0%
Q3 2018$1,249,000
+31125.0%
71,484
+7209.2%
0.01%
Q3 2017$4,000
-71.4%
978
-81.9%
0.00%
Q2 2017$14,000
-17.6%
5,4160.0%0.00%
Q1 2017$17,0005,4160.00%
Other shareholders
CHAMPIONS ONCOLOGY INC shareholders Q3 2017
NameSharesValueWeighting ↓
Battery Management Corp. 2,421,673$26,130,0006.61%
Roubaix Capital, LLC 206,502$2,228,0001.72%
Millrace Asset Group, Inc. 182,337$1,967,0001.37%
NEA Management Company, LLC 1,713,720$18,491,0000.49%
Zebra Capital Management LLC 32,084$346,0000.44%
Overbrook Management Corp 101,445$1,095,0000.27%
EAM Investors, LLC 99,763$1,076,0000.18%
Aristides Capital LLC 40,000$432,0000.15%
ESSEX INVESTMENT MANAGEMENT CO LLC 90,232$974,0000.12%
Cowen Prime Services LLC 13,500$146,0000.06%
View complete list of CHAMPIONS ONCOLOGY INC shareholders